The anti-IL-6R antibody has been successfully used for the treatment of rheumatoid arthritis and inflammatory diseases, and may be applicable for the treatment of other immune-mediated diseases including cancer [25, 26]. This evidence concerns the gene IL6R and rheumatoid arthritis.